Drugs News and Research

RSS

Possible new directions for treatments for addiction to cocaine

Cocaine causes specific alterations in the brain's circuitry at a genetic level, including short-term changes that result in a high from the cocaine, as well as long-term changes seen in addiction, researchers from UT Southwestern Medical Center have found.

23 Oct 2005

C. elegans, free-living soil nematodes, pave way for better anesthetics

Ten genes that may make patients more or less susceptible to a common anesthetic agent have been identified by researchers using tiny worms and sophisticated technology that eliminates the activity of individual genes.

23 Oct 2005

Teens with missing part of a chromosome confirm genetic role in schizophrenia

A study in youth who are missing part of a chromosome is further implicating a suspect gene in schizophrenia.

23 Oct 2005

Dopamine link to psychiatric and neurological disorders

A gene that regulates dopamine levels in the brain is involved in the development of schizophrenia in children at high risk for the disorder, say researchers at the Stanford University School of Medicine, Lucile Packard Children's Hospital and the University of Geneva.

23 Oct 2005

Situation-specific policies can reduce antibiotic resistance in hospital

The mass use of antibiotics has caused a rise of bacterial resistance to these drugs that is threatening to destroy the power of these life saving drugs.

23 Oct 2005

Traditional medical treatment of persistent cough may not be the most effective

The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

23 Oct 2005

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence.

23 Oct 2005

Deep brain stimulation can lower blood pressure

The possibility of a patient lowering their blood pressure at the flick of a switch has been raised by research led by Oxford University, which shows that stimulating parts of the brain with electrodes can change a patient’s blood pressure.

20 Oct 2005

Diabetes drugs may also prevent nerve degeneration caused by Alzheimer's disease

Recent research has shown a surprising link between Alzheimer’s and diabetes, two of the major health challenges facing society today. According to Dr Holscher modern lifestyle promotes the development of type 2 diabetes, which in turn could drastically increase the number of people to develop Alzheimer’s disease as people with type 2 diabetes are much more likely to develop the disease than healthy people of the same age.

20 Oct 2005

Successful prevention programs for children and adolescents

The future is bleak for children whose behavior seriously goes against the norm at a tender age. Early and long-term interventions make all the difference.

20 Oct 2005

Hepatitis C linked to illegal blood donation in China

Research in a rural province of central China has documented that illegal blood donation practices led to high hepatitis C virus (HCV) infection rates in blood and plasma donors during the 1980s and early 1990s, and that failure to screen for HCV in transfusion recipients increased their risk of infection as well

20 Oct 2005

Molecule P-glycoprotein (Pgp), may help reduce risk of Alzheimer's

A molecule that has long been an obstacle to cancer chemotherapy and drug treatments for brain disorders may soon become an ally in the fight against Alzheimer's disease, according to researchers at Washington University School of Medicine in St. Louis and the University of Rochester.

20 Oct 2005

Alzheimer disease and the blood brain barrier

Increased production of the amyloid-beta (Abeta) peptide can lead to Abeta aggregation and buildup in the brain and rare familial forms of early onset Alzheimer disease (AD).

20 Oct 2005

Avian flu and planning for pandemic

Influenza season is almost upon us. While it is impossible to tell whether we are going to experience a usual flu season -- with one in every five people falling ill -- or whether we are facing a more serious problem such as a dangerous new strain capable of causing a global pandemic, information is important.

20 Oct 2005

Breast cancer drug Herceptin a 'stunner'

According to the New England Journal of Medicine (NEJM) the first trials of the breast cancer drug, Herceptin, tested on women with early stage disease are "simply stunning".

20 Oct 2005

Zambia to try 'herbal remedy' as a treatment for HIV/AIDS

The United Nations paints a grim picture of the health situation in Zambia. One in every six adults in Zambia is living with HIV, life expectancy at birth is below 40 years and 630,000 children in Zambia are AIDS orphans.

20 Oct 2005

Good news for treating children with amblyopia

New research findings led by Thomas Krahe and Ary S. Ramoa of Virginia Commonwealth University School of Medicine offer two pieces of good news for treating children with amblyopia.

19 Oct 2005

Blocking macrophage migration inhibitory factor molecule might prevent the progression of multiple sclerosis

A new study suggests that a substance made by immune cells plays a key role in the progression of a disease in animals that closely mimics multiple sclerosis (MS). The findings further suggest that blocking the molecule, known as macrophage migration inhibitory factor (MIF) might prevent the progression of the disease.

19 Oct 2005

Research reveals possible mechanisms for the treatment of cocaine addiction

Researchers are now understanding in greater detail the molecular machinery underlying the short-term brain changes that produce the high of cocaine, as well as the longer-term changes behind addiction. Their findings offer hope for targeted drugs that can short-circuit that addiction machinery.

19 Oct 2005

Herceptin results "quite remarkable"

The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.

19 Oct 2005